113 related articles for article (PubMed ID: 15224807)
1. Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Koide H
Clin Nephrol; 2004 Jun; 61(6):429-33. PubMed ID: 15224807
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Ushiyama C; Osada S; Inoue T; Shimada N; Koide H
J Diabetes Complications; 2003; 17(6):349-54. PubMed ID: 14583180
[TBL] [Abstract][Full Text] [Related]
4. LDL apheresis in atherosclerotic disease with hyperlipidemia.
Naganuma S; Agishi T; Ota K
ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
[TBL] [Abstract][Full Text] [Related]
5. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: change in prostacyclin and effect on ischemic symptoms.
Mii S; Mori A; Sakata H; Nakayama M; Tsuruta H
Angiology; 1998 Mar; 49(3):175-80. PubMed ID: 9523539
[TBL] [Abstract][Full Text] [Related]
6. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
[TBL] [Abstract][Full Text] [Related]
7. [Arteriosclerosis obliterans that was improved by LDL apheresis].
Suzuki H; Mutoh E; Kitagawa T; Kubota H; Takasugi Y
Hokkaido Igaku Zasshi; 1993 Jan; 68(1):126-31. PubMed ID: 8444401
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
Nakamura T; Kawagoe Y; Ogawa H; Ueda Y; Hara M; Shimada N; Ebihara I; Koide H
Am J Kidney Dis; 2005 Jan; 45(1):48-53. PubMed ID: 15696443
[TBL] [Abstract][Full Text] [Related]
9. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
[TBL] [Abstract][Full Text] [Related]
10. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms.
Suzuki T; Sato Y; Niizuma S; Kushiro T; Tani S; Ishikawa K; Kajiwara N; Kanmatsuse K; Ikeda H; Takahashi M; Kojima S
J Clin Apher; 2007; 22(5):287-91. PubMed ID: 17610290
[TBL] [Abstract][Full Text] [Related]
12. [A case of acute renal and liver dysfunction with light chain deposition disease].
Ichikawa A; Hashimoto A; Shimizu A; Shizuku J; Abe Y; Wakai S; Ogura M; Ogawa T; Nitta K
Nihon Jinzo Gakkai Shi; 2007; 49(4):459-63. PubMed ID: 17578193
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis.
Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y
Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
15. Morphologic heterogeneity of renal light-chain deposition disease.
Gokden N; Barlogie B; Liapis H
Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
[TBL] [Abstract][Full Text] [Related]
16. Renal amyloidosis complicated by light chain deposition nephropathy: a case report.
Yu X; Lan P; Feng J; Feng X; Xie L
Int J Clin Exp Pathol; 2019; 12(6):2279-2283. PubMed ID: 31934052
[TBL] [Abstract][Full Text] [Related]
17. Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study.
Nakajima F; Morimoto S; Yurugi T; Amari Y; Kasuno Y; Fukui M; Furumatsu Y; Kitamura T
Int J Artif Organs; 2012 Nov; 35(11):981-5. PubMed ID: 23065872
[TBL] [Abstract][Full Text] [Related]
18. Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease.
Kamimura M; Matsuo M; Miyahara T; Kimura K; Matsumoto K; Nakaya T; Abe T; Akizawa T
Ther Apher; 2002 Dec; 6(6):467-70. PubMed ID: 12460413
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature
.
Mima A; Nagahara D; Tansho K
Clin Nephrol; 2018 Jun; 89(6):461-468. PubMed ID: 29393843
[TBL] [Abstract][Full Text] [Related]
20. [Light chain deposition disease. Experience in our environment].
Martín Herrera C; Suñer Poblet M; Cabrera R; Díaz Pedrero M; Fernández Alonso J
Nefrologia; 2008; 28(5):539-42. PubMed ID: 18816213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
